Which hedge funds own ENTA? ENANTA PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in ENTA (ENANTA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $55.9m in total. The largest holder by portfolio weight is Farallon Capital Management at 0.2% of its book. 1 exited: Tudor Investment.
6tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold ENTA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Farallon Capital Management | Q2 2026 | 0.2% | $35.3m | 2,418,202 | -16% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $8.1m | 557,600 | -16% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $9.4m | 643,967 | -27% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $1.9m | 131,995 | -37% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $741.3k | 50,844 | -81% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $503.6k | 34,539 | -51% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Tudor Investment | 0.0% | $131.1k |
How has hedge fund ownership of ENTA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $55.9m |
| Q1 2026 | 7 | $62.8m |
| Q4 2025 | 3 | $60.8m |
| Q3 2025 | 4 | $34.9m |
| Q2 2025 | 2 | $19.6m |
| Q1 2025 | 3 | $14.3m |
| Q4 2024 | 4 | $21.0m |
| Q3 2024 | 4 | $28.3m |
| Q2 2024 | 2 | $33.8m |
| Q1 2024 | 3 | $45.9m |
| Q4 2023 | 2 | $24.3m |
| Q3 2023 | 4 | $26.6m |
| Q2 2023 | 4 | $50.7m |
| Q1 2023 | 5 | $91.1m |
| Q4 2022 | 4 | $105.5m |
| Q3 2022 | 6 | $164.4m |
Counts every tracked manager that disclosed ENTA in that quarter's filing, including managers that have since stopped filing.